anaveon
  • About
    • Our Journey
    • About Us
    • Anaveon In Depth
  • Science
    • Our Approach
    • Publications
  • Team
    • Our Team
    • Our Board
    • Our Investors
  • News
  • Career
  • Contact Us
Select Page
HomeNovember
Anaveon announces poster presentation at the 2021 Society for Immunotherapy of Cancer Annual Meeting

Anaveon announces poster presentation at the 2021 Society for Immunotherapy of Cancer Annual Meeting

by admin | Nov 12, 2021 | Press Releases

Anaveon, a clinical stage, immuno-oncology company, today announced that it will present a poster on its lead program ANV419 at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting being held from Wednesday, November 10, 2021 to Sunday, November 14, 2021.

Search here

Categories

  • News 1
  • Press Releases 9

Recent Posts

  • Anaveon presents compelling data from the Phase I/II study of ANV419 during the AACR Annual Meeting 2022
    April 11, 2022
  • Anaveon to present first clinical data from the Phase I/II study of ANV419 at the AACR Annual Meeting 2022
    March 9, 2022
  • Anaveon_ gloved hand in laboratoryAnaveon to raise CHF 110 million in oversubscribed Series B financing
    December 16, 2021

We are social

Popular Tags

2020 AACR Annual Meeting anaveon brand clinical data CTA approval First patient investment news phase I phase I/II study phase II presentation press start trial study data team website

Archives

  • April 2022  1
  • March 2022  1
  • December 2021  1
  • November 2021  1
  • June 2021  1
  • March 2021  1
  • November 2020  1
  • May 2020  1
  • April 2019  1
  • February 2019  1
Anaveon_ submark

Contact us

Email

contact@anaveon.com

Postal Address

Anaveon AG

Technologiepark Basel

Hochbergerstrasse 60C

4057 Basel

Switzerland

Follow us

  • Linkedin
  • Home
  • Privacy Policy
  • Photography Credit

© 2020 All Rights Reserved